Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Kangmei Pharmaceutical Co., Ltd.    600518   CNE0000017M1

KANGMEI PHARMACEUTICAL CO., LTD.

(600518)
  Report
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
3.04 2.99 2.93 2.97 2.96 Last
40672000 21393450 21355200 20232200 15022740 Volume
-0.33% -1.64% -2.01% +1.37% -0.34% Change
Financials
Sales 2018 17 065 M 2 596 M 2 596 M
Net income 2018 374 M 57,0 M 57,0 M
Net Debt 2018 33 959 M 5 166 M 5 166 M
P/E ratio 2018 153x
Yield 2018 0,26%
Sales 2019 11 446 M 1 741 M 1 741 M
Net income 2019 -4 661 M -709 M -709 M
Net Debt 2019 31 913 M 4 855 M 4 855 M
P/E ratio 2019 -3,77x
Yield 2019 -
Capitalization 14 723 M 2 238 M 2 240 M
EV / Sales 2018 4,67x
EV / Sales 2019 4,41x
Nbr of Employees 9 209
Free-Float 51,0%
More Financials
Company
Kangmei Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products intended primarily for treating hypertension and colds. The group offers Chinese medications (ginseng, salvia, codonopsis, etc.) and chemical medications (clarithromycin, doxazosin mesylate, paracetamol, etc.). All sales are earned in China. 
More about the company
All news about KANGMEI PHARMACEUTICAL CO., LTD.
07/12China vows 'zero tolerance' towards illegal market behaviour
RE
06/15KANGMEI PHARMACEUTICAL CO., LTD. : annual earnings release
05/15China's securities watchdog pledges to clean up financial markets
RE
2019China's Kangmei Pharma sinks by daily limit as watchdog accuses it of fraud
RE
2019Chinese firms' missing $6 billion tests regulators' resolve
RE
2019As China pushes traditional medicine globally, illegal wildlife trade flouris..
RE
More news
News in other languages on KANGMEI PHARMACEUTICAL CO., LTD.
06/15KANGMEI PHARMACEUTICAL CO., LTD. : publication des résultats annuels
06/15KANGMEI PHARMACEUTICAL CO., LTD. : Veröffentlichung des Jahresergebnisses
More news
Chart KANGMEI PHARMACEUTICAL CO., LTD.
Duration : Period :
Kangmei Pharmaceutical Co., Ltd. Technical Analysis Chart | 600518 | CNE0000017M1 | MarketScreener
Technical analysis trends KANGMEI PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers
NameTitle
Guo Wei Liu General Manager
Xing Gu Ma Chairman
Guo Xiong Lin Chairman-Supervisory Board
Jin Cheng Wan Chief Financial Officer & Director
Zhen Ping Jiang Independent Director
Sector and Competitors